SAN FRANCISCO--(BUSINESS WIRE)--Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application ...

The addition of the 50-liter single-use bioreactor significantly expands Cellipont's cGMP-compliant capacity, enabling clients to seamlessly transition from early development to large-scale, ...

Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...